中国农业生物技术的研发能力、存在问题及改革建议  

R&D Ability,Existing Problems and Reform Recommendations of China's Agricultural Biotechnology

作　　者：胡瑞法[1] 王玉光[1] 蔡金阳[1] 黄季焜[2] 王晓兵[2] 

机构地区：[1]北京理工大学管理与经济学院,北京100081 [2]北京大学现代农学院,北京100871

出　　处：《中国软科学》2016年第7期27-32,共6页China Soft Science

基　　金：国家自然科学基金资助项目(71210004;71403019)

摘　　要：本文采用对国内承担转基因重大专项研究的全部研究单位研发能力的调查数据,结合Web of Science数据库全部转基因研究SCI论文检索数据和德温特数据库(DII)中转基因生物技术专利检索数据,研究了中国农业生物技术的研发能力及其研发体制。发现中国政府农业生物技术研发投资快速增长,中国转基因农业生物技术研发具有较强的国际竞争力;政府主导的以课题组为研发单位的转基因生物技术研发体制限制了国际竞争力的提升。为此,提出了整合上中下游研究机构,加强和强化"转化事件"等关键环节技术研究等政策建议。In the paper,we study the R＆D ability and the R＆D system of China＇ s agriculture biotechnology. Combing the survey data from all domestic undertakers about GM special project with GM SCI papers from Web of Science and GM patents from DII, we find that China＇ s GM R＆D investment increas rapidly and China has stronger international competitiveness on GM R＆D. However, the biotechnology R＆D system led by government through the research group for R＆D units has become an obstacle for enhancing its international competitiveness. Therefore, we give some corresponding policy suggestions, such as the integration of the upper,middle and lower research links and strengthen the transformation of the incident and other key aspects of technical research.

关 键 词：农作物 转基因 研发 能力 政策建议 

分 类 号：F323[经济管理—产业经济]